 Daniel Frank
Concepts (819)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 41 | 2024 | 781 | 5.510 |
Why?
| | Gastrointestinal Microbiome | 50 | 2026 | 771 | 5.310 |
Why?
| | Sinusitis | 17 | 2023 | 228 | 4.570 |
Why?
| | Rhinitis | 15 | 2022 | 171 | 4.550 |
Why?
| | RNA, Ribosomal, 16S | 49 | 2024 | 558 | 3.060 |
Why?
| | Bacteria | 34 | 2023 | 889 | 3.020 |
Why?
| | Metagenome | 15 | 2019 | 149 | 2.960 |
Why?
| | Paranasal Sinuses | 10 | 2023 | 81 | 2.230 |
Why?
| | Intestines | 15 | 2022 | 358 | 2.120 |
Why?
| | Dysbiosis | 18 | 2025 | 187 | 2.050 |
Why?
| | Otitis Media | 8 | 2025 | 181 | 1.990 |
Why?
| | Feces | 26 | 2026 | 513 | 1.890 |
Why?
| | Intestinal Mucosa | 21 | 2025 | 676 | 1.600 |
Why?
| | RNA, Bacterial | 12 | 2018 | 189 | 1.520 |
Why?
| | Nasal Polyps | 5 | 2021 | 59 | 1.400 |
Why?
| | Nose | 4 | 2018 | 68 | 1.340 |
Why?
| | Staphylococcus aureus | 6 | 2018 | 455 | 1.280 |
Why?
| | Nasal Cavity | 6 | 2023 | 62 | 1.240 |
Why?
| | Ileum | 5 | 2020 | 111 | 1.160 |
Why?
| | Sequence Analysis, DNA | 17 | 2020 | 824 | 1.140 |
Why?
| | Bacteremia | 6 | 2018 | 221 | 1.120 |
Why?
| | Crohn Disease | 6 | 2020 | 260 | 1.070 |
Why?
| | Phylogeny | 25 | 2020 | 1016 | 1.050 |
Why?
| | Staphylococcal Infections | 5 | 2018 | 388 | 1.020 |
Why?
| | Gastrointestinal Tract | 7 | 2022 | 208 | 1.000 |
Why?
| | Chronic Disease | 17 | 2022 | 1813 | 0.940 |
Why?
| | Burns | 6 | 2026 | 377 | 0.890 |
Why?
| | HIV Infections | 15 | 2025 | 3154 | 0.850 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 34 | 0.850 |
Why?
| | Bacterial Typing Techniques | 4 | 2015 | 44 | 0.830 |
Why?
| | Corynebacterium Infections | 3 | 2022 | 42 | 0.800 |
Why?
| | Clostridium Infections | 4 | 2018 | 74 | 0.790 |
Why?
| | Colon | 9 | 2025 | 304 | 0.770 |
Why?
| | Infant Nutritional Physiological Phenomena | 4 | 2025 | 149 | 0.770 |
Why?
| | Nasopharynx | 5 | 2024 | 73 | 0.770 |
Why?
| | Humans | 140 | 2025 | 144759 | 0.760 |
Why?
| | Endoribonucleases | 8 | 2002 | 80 | 0.760 |
Why?
| | Biodiversity | 13 | 2020 | 426 | 0.740 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.730 |
Why?
| | Breast Feeding | 7 | 2025 | 448 | 0.730 |
Why?
| | Bacterial Infections | 3 | 2015 | 246 | 0.730 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.730 |
Why?
| | Inflammation Mediators | 3 | 2023 | 509 | 0.710 |
Why?
| | Inflammatory Bowel Diseases | 7 | 2018 | 365 | 0.710 |
Why?
| | RNA, Catalytic | 7 | 2001 | 189 | 0.690 |
Why?
| | Database Management Systems | 2 | 2013 | 50 | 0.680 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.650 |
Why?
| | Male | 75 | 2026 | 72315 | 0.650 |
Why?
| | Drinking Water | 1 | 2022 | 97 | 0.650 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.650 |
Why?
| | Proton Pump Inhibitors | 2 | 2018 | 109 | 0.630 |
Why?
| | Inflammation | 13 | 2025 | 2878 | 0.630 |
Why?
| | User-Computer Interface | 2 | 2013 | 164 | 0.630 |
Why?
| | Molecular Sequence Data | 27 | 2015 | 2930 | 0.630 |
Why?
| | Female | 82 | 2026 | 78271 | 0.610 |
Why?
| | Diet | 9 | 2025 | 1273 | 0.600 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 142 | 0.600 |
Why?
| | Animals | 59 | 2026 | 38058 | 0.590 |
Why?
| | Polymerase Chain Reaction | 10 | 2018 | 1054 | 0.590 |
Why?
| | Software | 3 | 2021 | 690 | 0.590 |
Why?
| | Infant Food | 2 | 2025 | 64 | 0.580 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.580 |
Why?
| | HIV-1 | 8 | 2024 | 896 | 0.560 |
Why?
| | Sequence Analysis, RNA | 5 | 2020 | 442 | 0.550 |
Why?
| | Colitis, Ulcerative | 3 | 2020 | 147 | 0.550 |
Why?
| | RNA, Ribosomal | 8 | 2013 | 168 | 0.540 |
Why?
| | Adult | 48 | 2025 | 40449 | 0.540 |
Why?
| | Genes, rRNA | 3 | 2015 | 42 | 0.530 |
Why?
| | Iron | 3 | 2017 | 359 | 0.530 |
Why?
| | Mice | 32 | 2026 | 18339 | 0.510 |
Why?
| | Fatty Liver | 2 | 2021 | 251 | 0.510 |
Why?
| | Middle Aged | 41 | 2025 | 35875 | 0.500 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 141 | 0.490 |
Why?
| | Vagina | 5 | 2016 | 201 | 0.490 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 558 | 0.490 |
Why?
| | Membrane Proteins | 3 | 2021 | 1166 | 0.490 |
Why?
| | Butyrates | 3 | 2024 | 67 | 0.480 |
Why?
| | Pharynx | 1 | 2016 | 59 | 0.480 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2022 | 266 | 0.480 |
Why?
| | Nose Diseases | 1 | 2016 | 17 | 0.470 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 19 | 0.470 |
Why?
| | Case-Control Studies | 15 | 2020 | 3604 | 0.460 |
Why?
| | Base Sequence | 18 | 2015 | 2190 | 0.460 |
Why?
| | Biofilms | 5 | 2016 | 278 | 0.460 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 160 | 0.450 |
Why?
| | Food | 2 | 2020 | 149 | 0.440 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 73 | 0.440 |
Why?
| | Cross-Sectional Studies | 16 | 2023 | 5868 | 0.440 |
Why?
| | Endotoxemia | 2 | 2014 | 87 | 0.440 |
Why?
| | Immunity, Innate | 4 | 2019 | 846 | 0.440 |
Why?
| | Bacterial Translocation | 6 | 2026 | 52 | 0.430 |
Why?
| | Mice, Inbred C57BL | 18 | 2026 | 5992 | 0.420 |
Why?
| | Whole Genome Sequencing | 1 | 2015 | 182 | 0.410 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 47 | 0.400 |
Why?
| | Genome, Bacterial | 4 | 2016 | 155 | 0.400 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.390 |
Why?
| | Lactobacillus | 4 | 2022 | 28 | 0.390 |
Why?
| | Escherichia coli Proteins | 5 | 2016 | 206 | 0.390 |
Why?
| | Immunity, Mucosal | 4 | 2018 | 98 | 0.380 |
Why?
| | Iron, Dietary | 1 | 2013 | 23 | 0.380 |
Why?
| | Host-Pathogen Interactions | 3 | 2011 | 371 | 0.380 |
Why?
| | Immunoglobulin A | 4 | 2022 | 214 | 0.380 |
Why?
| | Hippocampus | 1 | 2018 | 965 | 0.380 |
Why?
| | Lipid Metabolism | 2 | 2020 | 527 | 0.380 |
Why?
| | Smoking | 2 | 2020 | 1472 | 0.370 |
Why?
| | Ear, Middle | 6 | 2025 | 85 | 0.370 |
Why?
| | Bacterial Load | 1 | 2012 | 67 | 0.370 |
Why?
| | Liver | 4 | 2020 | 1887 | 0.370 |
Why?
| | Colitis | 4 | 2025 | 280 | 0.370 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 248 | 0.360 |
Why?
| | Genitalia, Female | 1 | 2012 | 42 | 0.360 |
Why?
| | Asthma | 2 | 2015 | 1767 | 0.360 |
Why?
| | Probiotics | 5 | 2018 | 61 | 0.360 |
Why?
| | Gastrointestinal Diseases | 3 | 2017 | 216 | 0.360 |
Why?
| | Diet, High-Fat | 3 | 2019 | 261 | 0.350 |
Why?
| | Ethanol | 3 | 2026 | 627 | 0.340 |
Why?
| | Genomics | 5 | 2020 | 834 | 0.330 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1907 | 0.330 |
Why?
| | Alcohol Drinking | 3 | 2024 | 826 | 0.330 |
Why?
| | Livestock | 1 | 2010 | 11 | 0.330 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2012 | 428 | 0.330 |
Why?
| | Ribonucleoproteins, Small Nuclear | 4 | 1995 | 22 | 0.320 |
Why?
| | Isosorbide Dinitrate | 1 | 2010 | 3 | 0.320 |
Why?
| | Hydralazine | 1 | 2010 | 6 | 0.320 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2012 | 193 | 0.320 |
Why?
| | Antibodies, Fungal | 1 | 2010 | 9 | 0.320 |
Why?
| | Obesity | 7 | 2023 | 3077 | 0.320 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.320 |
Why?
| | DNA Primers | 3 | 2009 | 512 | 0.320 |
Why?
| | Stress, Psychological | 1 | 2018 | 1152 | 0.310 |
Why?
| | Cryptococcus neoformans | 1 | 2010 | 21 | 0.310 |
Why?
| | Fatty Acids, Volatile | 6 | 2024 | 60 | 0.310 |
Why?
| | Computational Biology | 3 | 2019 | 680 | 0.310 |
Why?
| | Alcohol-Related Disorders | 2 | 2008 | 120 | 0.310 |
Why?
| | Agriculture | 1 | 2010 | 104 | 0.300 |
Why?
| | Escherichia coli | 9 | 2017 | 854 | 0.300 |
Why?
| | Fluoroquinolones | 1 | 2009 | 44 | 0.300 |
Why?
| | Genome | 2 | 2009 | 306 | 0.300 |
Why?
| | Catheterization | 2 | 2009 | 183 | 0.300 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4557 | 0.300 |
Why?
| | Weight Loss | 3 | 2021 | 836 | 0.300 |
Why?
| | RNA, Small Nuclear | 3 | 1994 | 38 | 0.290 |
Why?
| | Infant | 17 | 2025 | 10034 | 0.290 |
Why?
| | Corynebacterium | 4 | 2022 | 49 | 0.290 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2008 | 3 | 0.280 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1169 | 0.280 |
Why?
| | Pancreatitis-Associated Proteins | 2 | 2025 | 12 | 0.280 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 863 | 0.280 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.270 |
Why?
| | Wound Infection | 1 | 2009 | 56 | 0.270 |
Why?
| | Aged | 19 | 2023 | 25913 | 0.270 |
Why?
| | Seafood | 2 | 2025 | 26 | 0.270 |
Why?
| | Behavior Therapy | 2 | 2021 | 299 | 0.270 |
Why?
| | Confidentiality | 1 | 2008 | 79 | 0.270 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 16 | 0.270 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 180 | 0.270 |
Why?
| | DNA, Bacterial | 6 | 2017 | 342 | 0.270 |
Why?
| | Pedigree | 4 | 2025 | 514 | 0.270 |
Why?
| | Milk, Human | 4 | 2023 | 172 | 0.270 |
Why?
| | Physicians, Primary Care | 1 | 2010 | 207 | 0.260 |
Why?
| | Transcriptome | 5 | 2021 | 1045 | 0.260 |
Why?
| | Eukaryotic Cells | 3 | 2007 | 40 | 0.260 |
Why?
| | Video Recording | 1 | 2008 | 212 | 0.260 |
Why?
| | Pneumonia | 2 | 2025 | 631 | 0.260 |
Why?
| | Genes, Bacterial | 5 | 2018 | 166 | 0.260 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 92 | 0.260 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 321 | 0.260 |
Why?
| | Congresses as Topic | 1 | 2008 | 221 | 0.250 |
Why?
| | RNA, Transfer | 3 | 1998 | 144 | 0.250 |
Why?
| | Perilipin-2 | 2 | 2017 | 40 | 0.250 |
Why?
| | Homeostasis | 5 | 2020 | 640 | 0.240 |
Why?
| | Nucleic Acid Conformation | 7 | 2002 | 726 | 0.240 |
Why?
| | Genotype | 4 | 2019 | 1833 | 0.240 |
Why?
| | Carrier Proteins | 1 | 2010 | 737 | 0.240 |
Why?
| | Genetic Background | 1 | 2026 | 16 | 0.240 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2017 | 62 | 0.240 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1126 | 0.240 |
Why?
| | DNA, Ribosomal | 7 | 2017 | 94 | 0.240 |
Why?
| | Dietary Supplements | 3 | 2019 | 576 | 0.230 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3890 | 0.230 |
Why?
| | Oxycodone | 1 | 2026 | 53 | 0.230 |
Why?
| | Blueberry Plants | 1 | 2025 | 8 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2363 | 0.230 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 1998 | 92 | 0.230 |
Why?
| | Biomarkers | 10 | 2025 | 4271 | 0.230 |
Why?
| | Diet, Western | 3 | 2022 | 86 | 0.230 |
Why?
| | Public Health | 1 | 2010 | 566 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.230 |
Why?
| | Research | 1 | 2008 | 431 | 0.220 |
Why?
| | Mice, Inbred NOD | 4 | 2022 | 610 | 0.220 |
Why?
| | Phenotype | 8 | 2020 | 3162 | 0.220 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 585 | 0.220 |
Why?
| | Attitude of Health Personnel | 2 | 2010 | 1185 | 0.220 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.220 |
Why?
| | Blood-Brain Barrier | 1 | 2026 | 155 | 0.220 |
Why?
| | Bile Acids and Salts | 3 | 2022 | 164 | 0.220 |
Why?
| | Neoplasms | 2 | 2018 | 2875 | 0.220 |
Why?
| | Pentanols | 1 | 2024 | 6 | 0.220 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 177 | 0.220 |
Why?
| | Construction Materials | 2 | 2015 | 18 | 0.210 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2017 | 549 | 0.210 |
Why?
| | Alcoholic Intoxication | 1 | 2025 | 74 | 0.210 |
Why?
| | Palatine Tonsil | 1 | 2024 | 55 | 0.210 |
Why?
| | Lyases | 1 | 2024 | 16 | 0.210 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 412 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 101 | 0.210 |
Why?
| | Cohort Studies | 7 | 2022 | 5960 | 0.210 |
Why?
| | Glycerophospholipids | 1 | 2024 | 39 | 0.210 |
Why?
| | Air Microbiology | 2 | 2015 | 50 | 0.210 |
Why?
| | Infant Formula | 2 | 2023 | 71 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 103 | 0.200 |
Why?
| | Adolescent | 14 | 2024 | 22428 | 0.200 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 176 | 0.200 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 28 | 0.200 |
Why?
| | Young Adult | 13 | 2024 | 14105 | 0.200 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 101 | 0.190 |
Why?
| | Pregnancy | 11 | 2025 | 7190 | 0.190 |
Why?
| | RNA Splicing | 3 | 1995 | 284 | 0.190 |
Why?
| | RNA, Fungal | 5 | 2002 | 73 | 0.190 |
Why?
| | Ear Canal | 1 | 2003 | 15 | 0.190 |
Why?
| | Species Specificity | 4 | 2020 | 574 | 0.190 |
Why?
| | Ribonuclease P | 7 | 2001 | 22 | 0.190 |
Why?
| | Sepsis | 2 | 2023 | 640 | 0.190 |
Why?
| | Alternative Splicing | 1 | 2025 | 247 | 0.190 |
Why?
| | Gene Ontology | 1 | 2022 | 53 | 0.190 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.190 |
Why?
| | Disease Susceptibility | 3 | 2020 | 348 | 0.190 |
Why?
| | Fungal Proteins | 2 | 2000 | 145 | 0.180 |
Why?
| | Mice, Knockout | 6 | 2025 | 3121 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 252 | 0.180 |
Why?
| | Genetic Variation | 4 | 2018 | 983 | 0.180 |
Why?
| | Mass Screening | 2 | 2008 | 1347 | 0.180 |
Why?
| | Olfaction Disorders | 1 | 2023 | 70 | 0.180 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 9 | 0.180 |
Why?
| | Mycobacterium | 1 | 2023 | 116 | 0.180 |
Why?
| | Exome | 2 | 2020 | 227 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 389 | 0.180 |
Why?
| | Immunity | 2 | 2014 | 139 | 0.180 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 118 | 0.180 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 474 | 0.180 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 60 | 0.170 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2022 | 1129 | 0.170 |
Why?
| | Child, Preschool | 10 | 2025 | 11787 | 0.170 |
Why?
| | Rats | 9 | 2026 | 5597 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 233 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 198 | 0.170 |
Why?
| | Genes, Fungal | 4 | 2000 | 55 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Child | 12 | 2025 | 22633 | 0.170 |
Why?
| | Nutritional Status | 2 | 2014 | 354 | 0.160 |
Why?
| | Health | 2 | 2012 | 81 | 0.160 |
Why?
| | Ascomycota | 1 | 2000 | 28 | 0.160 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.160 |
Why?
| | Plasminogen | 1 | 2020 | 27 | 0.160 |
Why?
| | Cecum | 4 | 2026 | 37 | 0.160 |
Why?
| | Islets of Langerhans | 3 | 2015 | 833 | 0.160 |
Why?
| | Mice, Nude | 1 | 2022 | 682 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Mucin 5AC | 1 | 2020 | 70 | 0.160 |
Why?
| | Mouth | 1 | 2020 | 88 | 0.160 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 300 | 0.160 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 5 | 2002 | 579 | 0.160 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.160 |
Why?
| | Carcinogenesis | 1 | 2022 | 229 | 0.150 |
Why?
| | Body Mass Index | 5 | 2020 | 2438 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 233 | 0.150 |
Why?
| | Vascular Remodeling | 1 | 2021 | 205 | 0.150 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 136 | 0.150 |
Why?
| | Aged, 80 and over | 6 | 2021 | 8265 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 20 | 0.150 |
Why?
| | Double-Blind Method | 4 | 2025 | 2029 | 0.150 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.150 |
Why?
| | Autoimmunity | 3 | 2015 | 926 | 0.150 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 51 | 0.150 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 16 | 0.150 |
Why?
| | Vitamin B Complex | 1 | 2019 | 40 | 0.150 |
Why?
| | Infant, Newborn | 5 | 2025 | 6429 | 0.150 |
Why?
| | Surveys and Questionnaires | 3 | 2009 | 6048 | 0.140 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 181 | 0.140 |
Why?
| | Restraint, Physical | 1 | 2018 | 75 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2145 | 0.140 |
Why?
| | Oxonic Acid | 1 | 2018 | 13 | 0.140 |
Why?
| | Organic Chemicals | 1 | 2020 | 127 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 366 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 340 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 47 | 0.140 |
Why?
| | Microbiological Techniques | 2 | 2016 | 33 | 0.140 |
Why?
| | Vitamin B 12 | 1 | 2019 | 127 | 0.140 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2168 | 0.140 |
Why?
| | Corrosion | 2 | 2015 | 16 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 109 | 0.140 |
Why?
| | Colony Count, Microbial | 3 | 2016 | 122 | 0.130 |
Why?
| | Random Allocation | 1 | 2018 | 363 | 0.130 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2018 | 26 | 0.130 |
Why?
| | Immunoglobulin D | 1 | 2017 | 29 | 0.130 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.130 |
Why?
| | Evolution, Molecular | 2 | 2018 | 514 | 0.130 |
Why?
| | Respiratory Sounds | 1 | 2018 | 105 | 0.130 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 6 | 0.130 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.130 |
Why?
| | Meta-Analysis as Topic | 2 | 2008 | 174 | 0.130 |
Why?
| | Cytokines | 5 | 2025 | 2061 | 0.130 |
Why?
| | Birth Weight | 1 | 2020 | 522 | 0.130 |
Why?
| | Bacterial Toxins | 1 | 2018 | 109 | 0.130 |
Why?
| | Analgesics, Opioid | 1 | 2026 | 1143 | 0.130 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 41 | 0.130 |
Why?
| | Lung | 4 | 2022 | 4109 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Water Microbiology | 3 | 2016 | 90 | 0.130 |
Why?
| | Prospective Studies | 4 | 2020 | 7990 | 0.130 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 114 | 0.130 |
Why?
| | Ceftriaxone | 1 | 2016 | 21 | 0.120 |
Why?
| | Autoantibodies | 3 | 2022 | 1501 | 0.120 |
Why?
| | Gene Expression | 2 | 2018 | 1490 | 0.120 |
Why?
| | Micronutrients | 1 | 2017 | 96 | 0.120 |
Why?
| | Metals | 1 | 1997 | 142 | 0.120 |
Why?
| | beta-Lactamases | 1 | 2016 | 51 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.120 |
Why?
| | Pelvic Infection | 1 | 2016 | 6 | 0.120 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 70 | 0.120 |
Why?
| | Metabolome | 1 | 2020 | 384 | 0.120 |
Why?
| | Down Syndrome | 1 | 2023 | 534 | 0.120 |
Why?
| | Oligonucleotide Probes | 3 | 2005 | 50 | 0.120 |
Why?
| | Tissue Adhesives | 1 | 2016 | 22 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 612 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 121 | 0.120 |
Why?
| | Salmonella Infections | 1 | 2016 | 60 | 0.120 |
Why?
| | Bacillus | 1 | 2015 | 17 | 0.120 |
Why?
| | Binding Sites | 6 | 1998 | 1329 | 0.120 |
Why?
| | Cholesterol | 3 | 2023 | 406 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 6 | 0.120 |
Why?
| | Vaccines, Attenuated | 1 | 2016 | 129 | 0.120 |
Why?
| | Symbiosis | 2 | 2017 | 81 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 69 | 0.120 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.120 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.120 |
Why?
| | Gelatin | 1 | 2016 | 56 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Interleukin-6 | 2 | 2017 | 780 | 0.110 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.110 |
Why?
| | Rhinitis, Allergic | 1 | 2016 | 42 | 0.110 |
Why?
| | Lymph | 1 | 2015 | 31 | 0.110 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 23 | 0.110 |
Why?
| | RNA, Messenger | 4 | 2018 | 2832 | 0.110 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 60 | 0.110 |
Why?
| | Catalase | 1 | 2015 | 130 | 0.110 |
Why?
| | Dietary Fats | 1 | 2017 | 314 | 0.110 |
Why?
| | Metagenomics | 2 | 2019 | 181 | 0.110 |
Why?
| | Sanitary Engineering | 1 | 2015 | 6 | 0.110 |
Why?
| | Thrombophilia | 1 | 2016 | 88 | 0.110 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 264 | 0.110 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 60 | 0.110 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.110 |
Why?
| | Hysterectomy | 1 | 2016 | 137 | 0.110 |
Why?
| | Thrombin | 1 | 2016 | 166 | 0.110 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.110 |
Why?
| | Rectum | 1 | 2016 | 180 | 0.110 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 40 | 0.110 |
Why?
| | Health Facilities | 1 | 2015 | 85 | 0.110 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 190 | 0.110 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 157 | 0.110 |
Why?
| | Hospitalization | 3 | 2018 | 2433 | 0.110 |
Why?
| | Carrier State | 1 | 2015 | 79 | 0.110 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 96 | 0.110 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2115 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 195 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 28 | 0.110 |
Why?
| | Physical Exertion | 1 | 2015 | 207 | 0.110 |
Why?
| | Bacterial Adhesion | 1 | 2015 | 109 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 52 | 0.110 |
Why?
| | Gentamicins | 1 | 2015 | 51 | 0.110 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 129 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 245 | 0.110 |
Why?
| | Mucous Membrane | 1 | 2015 | 127 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 920 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 129 | 0.100 |
Why?
| | Genetics, Medical | 2 | 2011 | 23 | 0.100 |
Why?
| | Biota | 1 | 2014 | 35 | 0.100 |
Why?
| | Bifidobacterium | 3 | 2022 | 21 | 0.100 |
Why?
| | Adiposity | 2 | 2018 | 543 | 0.100 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 1994 | 11 | 0.100 |
Why?
| | Maternal Welfare | 1 | 2014 | 21 | 0.100 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 130 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 653 | 0.100 |
Why?
| | Diabetes Mellitus | 2 | 2013 | 1098 | 0.100 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 28 | 0.100 |
Why?
| | Body Weight | 2 | 2015 | 976 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 983 | 0.100 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 48 | 0.100 |
Why?
| | Hypoxia | 1 | 2021 | 1199 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 675 | 0.100 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 59 | 0.100 |
Why?
| | Consensus | 1 | 2016 | 488 | 0.100 |
Why?
| | Nutrition Assessment | 1 | 2014 | 92 | 0.100 |
Why?
| | Preconception Care | 1 | 2014 | 50 | 0.100 |
Why?
| | Railroads | 1 | 2013 | 6 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 21 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 218 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 67 | 0.100 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 201 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 845 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 549 | 0.090 |
Why?
| | Gastric Bypass | 1 | 2014 | 125 | 0.090 |
Why?
| | Zinc Fingers | 1 | 1992 | 53 | 0.090 |
Why?
| | Burkina Faso | 1 | 2012 | 7 | 0.090 |
Why?
| | Pediatric Obesity | 1 | 2020 | 637 | 0.090 |
Why?
| | Drug Combinations | 2 | 2012 | 390 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 242 | 0.090 |
Why?
| | Paneth Cells | 1 | 2012 | 20 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 32 | 0.090 |
Why?
| | Antibodies, Viral | 1 | 2016 | 672 | 0.090 |
Why?
| | Aerosols | 1 | 2013 | 186 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 67 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 732 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 478 | 0.090 |
Why?
| | Influenza Vaccines | 1 | 2016 | 529 | 0.090 |
Why?
| | Prenatal Care | 1 | 2014 | 307 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 144 | 0.090 |
Why?
| | Skin | 1 | 2016 | 755 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 758 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 173 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2018 | 955 | 0.080 |
Why?
| | Lactation | 1 | 2012 | 192 | 0.080 |
Why?
| | Nutritive Value | 1 | 2010 | 38 | 0.080 |
Why?
| | Food Safety | 1 | 2010 | 22 | 0.080 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 281 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1495 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 419 | 0.080 |
Why?
| | Bacterial Capsules | 1 | 2010 | 33 | 0.080 |
Why?
| | Amphotericin B | 1 | 2010 | 37 | 0.080 |
Why?
| | Viruses | 1 | 2012 | 165 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1980 | 0.080 |
Why?
| | Meningitis, Cryptococcal | 1 | 2010 | 34 | 0.080 |
Why?
| | Staphylococcus epidermidis | 1 | 2010 | 77 | 0.080 |
Why?
| | Insulin | 2 | 2022 | 2507 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 92 | 0.080 |
Why?
| | Cluster Analysis | 3 | 2017 | 521 | 0.080 |
Why?
| | Urinary Catheterization | 1 | 2009 | 33 | 0.080 |
Why?
| | Risk Factors | 4 | 2018 | 10779 | 0.080 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1519 | 0.070 |
Why?
| | Prostatectomy | 1 | 2009 | 93 | 0.070 |
Why?
| | Biomass | 1 | 2009 | 116 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2018 | 11679 | 0.070 |
Why?
| | Montana | 1 | 2009 | 19 | 0.070 |
Why?
| | Mississippi | 1 | 2009 | 29 | 0.070 |
Why?
| | Sequence Alignment | 3 | 2001 | 366 | 0.070 |
Why?
| | Fatty Acids | 3 | 2022 | 450 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 96 | 0.070 |
Why?
| | Prevalence | 2 | 2014 | 2834 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2017 | 1173 | 0.070 |
Why?
| | Permeability | 2 | 2022 | 168 | 0.070 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 141 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 917 | 0.070 |
Why?
| | Environment | 1 | 2010 | 305 | 0.070 |
Why?
| | Rats, Inbred Lew | 3 | 2017 | 103 | 0.070 |
Why?
| | Systems Integration | 1 | 2008 | 36 | 0.070 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 321 | 0.070 |
Why?
| | Models, Statistical | 1 | 2013 | 681 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2022 | 17066 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 1985 | 0.070 |
Why?
| | Housing | 1 | 2009 | 144 | 0.070 |
Why?
| | Down-Regulation | 2 | 2024 | 627 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2583 | 0.070 |
Why?
| | RNA Precursors | 4 | 1998 | 156 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2608 | 0.070 |
Why?
| | Ecosystem | 2 | 2010 | 589 | 0.070 |
Why?
| | Gram-Negative Bacteria | 2 | 2004 | 81 | 0.070 |
Why?
| | Geologic Sediments | 1 | 2007 | 45 | 0.070 |
Why?
| | Physicians, Family | 1 | 2009 | 173 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2008 | 121 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2947 | 0.070 |
Why?
| | Prognosis | 2 | 2020 | 4282 | 0.060 |
Why?
| | Child Development | 1 | 2012 | 484 | 0.060 |
Why?
| | Urinary Tract Infections | 1 | 2009 | 202 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2013 | 790 | 0.060 |
Why?
| | Plasmids | 4 | 2016 | 379 | 0.060 |
Why?
| | Focus Groups | 1 | 2010 | 573 | 0.060 |
Why?
| | Residence Characteristics | 1 | 2010 | 377 | 0.060 |
Why?
| | Cross Infection | 1 | 2009 | 262 | 0.060 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 221 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3409 | 0.060 |
Why?
| | Indomethacin | 1 | 2006 | 76 | 0.060 |
Why?
| | Peptic Ulcer | 1 | 2006 | 18 | 0.060 |
Why?
| | Enterococcus faecalis | 1 | 2006 | 28 | 0.060 |
Why?
| | Research Personnel | 1 | 2008 | 186 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2000 | 570 | 0.060 |
Why?
| | Common Variable Immunodeficiency | 1 | 2006 | 26 | 0.060 |
Why?
| | Proteobacteria | 2 | 2017 | 16 | 0.060 |
Why?
| | Opportunistic Infections | 1 | 2006 | 45 | 0.060 |
Why?
| | Kenya | 2 | 2017 | 129 | 0.060 |
Why?
| | Autoantigens | 2 | 2022 | 429 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2022 | 893 | 0.060 |
Why?
| | Self Administration | 1 | 2026 | 124 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 851 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 197 | 0.060 |
Why?
| | Inpatients | 1 | 2010 | 545 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 166 | 0.060 |
Why?
| | Clostridium | 2 | 2017 | 19 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 57 | 0.060 |
Why?
| | Short Bowel Syndrome | 1 | 2005 | 27 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 63 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1996 | 540 | 0.050 |
Why?
| | Hexanols | 1 | 2024 | 7 | 0.050 |
Why?
| | Body Composition | 2 | 2021 | 706 | 0.050 |
Why?
| | Cystic Fibrosis | 1 | 2015 | 1158 | 0.050 |
Why?
| | Fruit | 1 | 2025 | 152 | 0.050 |
Why?
| | Oropharynx | 1 | 2024 | 46 | 0.050 |
Why?
| | In Situ Hybridization | 1 | 2005 | 319 | 0.050 |
Why?
| | Age Factors | 2 | 2025 | 3333 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2005 | 322 | 0.050 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 88 | 0.050 |
Why?
| | Methylamines | 1 | 2024 | 40 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 187 | 0.050 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2005 | 69 | 0.050 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 63 | 0.050 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 187 | 0.050 |
Why?
| | Hydrogen Bonding | 2 | 1994 | 169 | 0.050 |
Why?
| | Comorbidity | 1 | 2009 | 1658 | 0.050 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 12 | 0.050 |
Why?
| | Artificial Intelligence | 1 | 2008 | 365 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1769 | 0.050 |
Why?
| | Bites and Stings | 1 | 2004 | 29 | 0.050 |
Why?
| | Zoonoses | 1 | 2004 | 36 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 53 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1217 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 88 | 0.050 |
Why?
| | Microglia | 1 | 2026 | 268 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 338 | 0.050 |
Why?
| | Cats | 1 | 2004 | 228 | 0.050 |
Why?
| | Choline | 1 | 2024 | 136 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 561 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2527 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 118 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Gram-Negative Anaerobic Bacteria | 1 | 2002 | 2 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 547 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 65 | 0.050 |
Why?
| | alpha-Defensins | 1 | 2022 | 11 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 854 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 35 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 218 | 0.050 |
Why?
| | Fetal Death | 1 | 2002 | 58 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 181 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 48 | 0.050 |
Why?
| | Glycerol | 1 | 2022 | 90 | 0.050 |
Why?
| | Pilot Projects | 2 | 2018 | 1886 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 526 | 0.040 |
Why?
| | Virulence | 1 | 2023 | 278 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 2002 | 79 | 0.040 |
Why?
| | Smell | 1 | 2023 | 128 | 0.040 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 334 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1992 | 381 | 0.040 |
Why?
| | Granzymes | 1 | 2022 | 49 | 0.040 |
Why?
| | Algorithms | 1 | 2009 | 1837 | 0.040 |
Why?
| | Multigene Family | 2 | 2012 | 204 | 0.040 |
Why?
| | Japan | 1 | 2021 | 143 | 0.040 |
Why?
| | Immunity, Humoral | 1 | 2022 | 120 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 673 | 0.040 |
Why?
| | Pigments, Biological | 1 | 2001 | 17 | 0.040 |
Why?
| | RNA, Archaeal | 1 | 2001 | 11 | 0.040 |
Why?
| | Systole | 1 | 2021 | 178 | 0.040 |
Why?
| | Diet, Reducing | 1 | 2021 | 91 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 456 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 433 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 139 | 0.040 |
Why?
| | Tight Junctions | 1 | 2021 | 81 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 22 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 150 | 0.040 |
Why?
| | Consensus Sequence | 1 | 2000 | 74 | 0.040 |
Why?
| | Macrophages | 2 | 2021 | 1511 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 252 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5408 | 0.040 |
Why?
| | DNA, Fungal | 1 | 2000 | 83 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 437 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1716 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 99 | 0.040 |
Why?
| | Microvessels | 1 | 2021 | 99 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 397 | 0.040 |
Why?
| | Abortion, Spontaneous | 1 | 2001 | 115 | 0.040 |
Why?
| | Caloric Restriction | 1 | 2021 | 127 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2003 | 375 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 548 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 63 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 232 | 0.040 |
Why?
| | Fasting | 1 | 2021 | 277 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 115 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 80 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 361 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 184 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 157 | 0.040 |
Why?
| | Catalysis | 2 | 1998 | 322 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 179 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 4089 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 147 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 7173 | 0.040 |
Why?
| | Substrate Specificity | 2 | 1997 | 388 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 136 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 249 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 55 | 0.040 |
Why?
| | RNA, Transfer, Asp | 1 | 1998 | 3 | 0.040 |
Why?
| | Serine Endopeptidases | 2 | 1989 | 128 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 181 | 0.030 |
Why?
| | Collagen Type II | 1 | 2018 | 54 | 0.030 |
Why?
| | Lipids | 1 | 2023 | 710 | 0.030 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.030 |
Why?
| | Prokaryotic Cells | 1 | 1998 | 6 | 0.030 |
Why?
| | Acute Disease | 2 | 2016 | 1030 | 0.030 |
Why?
| | Magnesium | 1 | 1998 | 155 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 594 | 0.030 |
Why?
| | Syndecan-1 | 1 | 2017 | 42 | 0.030 |
Why?
| | Powders | 1 | 2017 | 44 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 601 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 85 | 0.030 |
Why?
| | Plasma Cells | 1 | 2017 | 75 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 166 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 451 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 479 | 0.030 |
Why?
| | Mucus | 1 | 2017 | 73 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1253 | 0.030 |
Why?
| | Prophages | 1 | 2016 | 9 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1047 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 200 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 66 | 0.030 |
Why?
| | Ciprofloxacin | 1 | 2016 | 26 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 94 | 0.030 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2016 | 38 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 847 | 0.030 |
Why?
| | Heart Failure | 1 | 2010 | 2323 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 760 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 69 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 126 | 0.030 |
Why?
| | Primary Health Care | 1 | 2007 | 1733 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2017 | 271 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 27 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 28 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 284 | 0.030 |
Why?
| | Rifamycins | 1 | 2016 | 6 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 766 | 0.030 |
Why?
| | Zebrafish | 1 | 2000 | 528 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2925 | 0.030 |
Why?
| | Sulfasalazine | 1 | 2016 | 22 | 0.030 |
Why?
| | Macaca nemestrina | 1 | 2016 | 29 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 108 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 744 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 71 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 180 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 365 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 27 | 0.030 |
Why?
| | North America | 1 | 2016 | 310 | 0.030 |
Why?
| | Mesentery | 1 | 2015 | 45 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 8 | 0.030 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2016 | 92 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 370 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 26 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 869 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 652 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 60 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 40 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 508 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 21 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 160 | 0.030 |
Why?
| | Bacterial Shedding | 1 | 2014 | 3 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 90 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1135 | 0.030 |
Why?
| | snRNP Core Proteins | 1 | 1994 | 4 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 33 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 1994 | 48 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 424 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 78 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 96 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 502 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 727 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2027 | 0.030 |
Why?
| | Methane | 1 | 2014 | 51 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 57 | 0.030 |
Why?
| | Models, Genetic | 2 | 1995 | 536 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 37 | 0.030 |
Why?
| | Models, Animal | 1 | 2015 | 392 | 0.030 |
Why?
| | Geography | 1 | 2014 | 203 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2013 | 22 | 0.020 |
Why?
| | Observer Variation | 1 | 2014 | 355 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2016 | 340 | 0.020 |
Why?
| | Brain | 1 | 2026 | 2933 | 0.020 |
Why?
| | Sequence Deletion | 1 | 1994 | 193 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 262 | 0.020 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 277 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 397 | 0.020 |
Why?
| | Cell Lineage | 1 | 2015 | 376 | 0.020 |
Why?
| | Glycoproteins | 1 | 2015 | 355 | 0.020 |
Why?
| | New York City | 1 | 2013 | 89 | 0.020 |
Why?
| | Diarrhea | 1 | 2014 | 192 | 0.020 |
Why?
| | Genes, Synthetic | 1 | 1992 | 14 | 0.020 |
Why?
| | Perioperative Care | 1 | 2015 | 231 | 0.020 |
Why?
| | Genes, Lethal | 1 | 1992 | 30 | 0.020 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.020 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2882 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.020 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 556 | 0.020 |
Why?
| | Staphylococcus | 1 | 2013 | 74 | 0.020 |
Why?
| | Endoscopy | 1 | 2015 | 316 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 84 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 321 | 0.020 |
Why?
| | Cattle | 2 | 2005 | 1000 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 288 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 496 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 9 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1539 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 316 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 775 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 194 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 51 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1966 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 427 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 396 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 555 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 105 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2847 | 0.020 |
Why?
| | Milk | 1 | 2012 | 119 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 784 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 675 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 419 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1339 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 499 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 415 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 128 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 5226 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 462 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 628 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 114 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 436 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 248 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1187 | 0.020 |
Why?
| | Hospitals | 1 | 2015 | 730 | 0.020 |
Why?
| | Risk Assessment | 2 | 2014 | 3671 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2327 | 0.020 |
Why?
| | Gestational Age | 1 | 2014 | 975 | 0.020 |
Why?
| | Influenza, Human | 1 | 2016 | 616 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1075 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1306 | 0.020 |
Why?
| | Legionella | 1 | 2009 | 9 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 21 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 475 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 902 | 0.020 |
Why?
| | Boronic Acids | 1 | 1989 | 37 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 318 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3185 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 1989 | 15 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 199 | 0.020 |
Why?
| | Clinical Medicine | 1 | 2009 | 26 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 501 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2155 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3863 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1782 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1499 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 416 | 0.020 |
Why?
| | Washington | 1 | 2007 | 147 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1423 | 0.020 |
Why?
| | RNA | 1 | 2013 | 940 | 0.020 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2006 | 28 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 995 | 0.010 |
Why?
| | Internal Medicine | 1 | 2009 | 280 | 0.010 |
Why?
| | Pediatrics | 1 | 2014 | 1114 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2013 | 2496 | 0.010 |
Why?
| | Biomedical Research | 1 | 2012 | 710 | 0.010 |
Why?
| | Amino Acids | 1 | 1989 | 521 | 0.010 |
Why?
| | Guinea Pigs | 1 | 2005 | 159 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2005 | 12 | 0.010 |
Why?
| | Culture Media | 1 | 2005 | 161 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 541 | 0.010 |
Why?
| | United States | 2 | 2015 | 15966 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2430 | 0.010 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2005 | 131 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 312 | 0.010 |
Why?
| | Risk-Taking | 1 | 2007 | 328 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 122 | 0.010 |
Why?
| | Protein Conformation | 2 | 2002 | 946 | 0.010 |
Why?
| | Sputum | 1 | 2005 | 308 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2016 | 2919 | 0.010 |
Why?
| | Gastrostomy | 1 | 2005 | 130 | 0.010 |
Why?
| | Psychometrics | 1 | 2007 | 734 | 0.010 |
Why?
| | Pregnancy Trimester, Second | 1 | 2002 | 82 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2007 | 600 | 0.010 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2002 | 51 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1047 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2005 | 1266 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2009 | 1356 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 47 | 0.010 |
Why?
| | Hydrolysis | 1 | 1998 | 199 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 592 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1998 | 69 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1995 | 26 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 1995 | 64 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1627 | 0.010 |
Why?
| | Mutagenesis | 1 | 1995 | 192 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4154 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1995 | 498 | 0.010 |
Why?
| | Crystallography | 1 | 1989 | 28 | 0.000 |
Why?
| | Chemistry | 1 | 1989 | 41 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1989 | 81 | 0.000 |
Why?
| | Genes | 1 | 1989 | 226 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1989 | 337 | 0.000 |
Why?
| | Recombinant Proteins | 1 | 1989 | 1370 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|